HEMATOXYLIN

HEMATOXYLIN is a lipid of Polyketides (PK) class. Hematoxylin is associated with abnormalities such as Eosinophilia, Duodenal Adenoma, Senile Plaques, Morphologically altered structure and Cervical abscess. The involved functions are known as Uptake, Apoptosis, Amplification, Necrosis and Karyopyknosis. Hematoxylin often locates in Body tissue, Extracellular, Compact bone, Skin and Basement membrane. The associated genes with HEMATOXYLIN are GAPDH gene, Genome, Elastin, MERTK wt Allele and P4HTM gene.

Cross Reference

Introduction

To understand associated biological information of HEMATOXYLIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with HEMATOXYLIN?

HEMATOXYLIN is suspected in Senile Plaques, Eosinophilia, Duodenal Adenoma, Morphologically altered structure, Cervical abscess and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with HEMATOXYLIN

MeSH term MeSH ID Detail
Tuberculosis D014376 20 associated lipids
Stomach Ulcer D013276 75 associated lipids
Diarrhea D003967 32 associated lipids
Uterine Cervical Neoplasms D002583 10 associated lipids
Carcinoma, Basal Cell D002280 6 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Tumor Virus Infections D014412 8 associated lipids
Adenocarcinoma D000230 166 associated lipids
Breast Neoplasms D001943 24 associated lipids
Sarcoma D012509 3 associated lipids
Bacterial Infections D001424 21 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Mouth Diseases D009059 5 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Skin Neoplasms D012878 12 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Precancerous Conditions D011230 48 associated lipids
Stomach Neoplasms D013274 24 associated lipids
Carcinoma D002277 18 associated lipids
Neoplasm Recurrence, Local D009364 5 associated lipids
Femoral Neck Fractures D005265 3 associated lipids
Granuloma D006099 5 associated lipids
Rodent Diseases D012376 4 associated lipids
Coronary Disease D003327 70 associated lipids
Osteosarcoma D012516 50 associated lipids
Carcinoma, Small Cell D018288 21 associated lipids
Brain Neoplasms D001932 15 associated lipids
Hypothyroidism D007037 32 associated lipids
Embolism D004617 3 associated lipids
Heart Diseases D006331 8 associated lipids
Occupational Diseases D009784 42 associated lipids
Brain Diseases D001927 27 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Bone Diseases D001847 4 associated lipids
Calcinosis D002114 5 associated lipids
Myocardial Infarction D009203 21 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Alzheimer Disease D000544 76 associated lipids
Teratoma D013724 4 associated lipids
Hyperplasia D006965 34 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Peripheral Nervous System Diseases D010523 33 associated lipids
Dental Pulp Necrosis D003790 6 associated lipids
Lymphoproliferative Disorders D008232 7 associated lipids
Per page 10 20 50 100 | Total 146

PubChem Associated disorders and diseases

What pathways are associated with HEMATOXYLIN

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with HEMATOXYLIN?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with HEMATOXYLIN?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

What genes are associated with HEMATOXYLIN?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with HEMATOXYLIN

Download all related citations
Per page 10 20 50 100 | Total 5340
Authors Title Published Journal PubMed Link
Costa-Nogueira C et al. Synthesis and expression of CDw75 antigen in human colorectal cancer. 2009 BMC Cancer pmid:20003255
Zhang B et al. Expression of RECK and matrix metalloproteinase-2 in ameloblastoma. 2009 BMC Cancer pmid:19995435
Kahlert C et al. Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer. 2011 BMC Cancer pmid:21708005
Sanz-Santos J et al. Contribution of cell blocks obtained through endobronchial ultrasound-guided transbronchial needle aspiration to the diagnosis of lung cancer. 2012 BMC Cancer pmid:22264305
Pinho SS et al. Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression. 2007 BMC Cancer pmid:17617904
Alam H et al. Fascin overexpression promotes neoplastic progression in oral squamous cell carcinoma. 2012 BMC Cancer pmid:22264292
de Kruijf EM et al. NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study. 2012 BMC Cancer pmid:22257486
Wang Q et al. Zinc finger protein ZBTB20 expression is increased in hepatocellular carcinoma and associated with poor prognosis. 2011 BMC Cancer pmid:21702992
Gambichler T et al. Pattern of mRNA expression of beta-defensins in basal cell carcinoma. 2006 BMC Cancer pmid:16796735
Morgan K et al. GnRH receptor activation competes at a low level with growth signaling in stably transfected human breast cell lines. 2011 BMC Cancer pmid:22051164
Hamtiaux L et al. The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action. 2012 BMC Cancer pmid:22429826
Kim JH et al. Canine classical seminoma: a specific malignant type with human classifications is highly correlated with tumor angiogenesis. 2010 BMC Cancer pmid:20509912
Egerod FL et al. High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression. 2009 BMC Cancer pmid:19878561
van Rossum AG et al. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice. 2006 BMC Cancer pmid:16536875
González-Reyes S et al. Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis. 2010 BMC Cancer pmid:21129170
Chen M et al. Overexpression of eIF-5A2 in mice causes accelerated organismal aging by increasing chromosome instability. 2011 BMC Cancer pmid:21612665
Van Damme N et al. Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas. 2010 BMC Cancer pmid:20459770
Moelans CB et al. HER-2/neu amplification testing in breast cancer by Multiplex Ligation-dependent Probe Amplification: influence of manual- and laser microdissection. 2009 BMC Cancer pmid:19123950
Kavanagh DO et al. Is overexpression of HER-2 a predictor of prognosis in colorectal cancer? 2009 BMC Cancer pmid:19118499
Chanrion M et al. A new molecular breast cancer subclass defined from a large scale real-time quantitative RT-PCR study. 2007 BMC Cancer pmid:17338809
Wu Z et al. Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma. 2009 BMC Cancer pmid:19732464
Brennan DJ et al. Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer. 2010 BMC Cancer pmid:20359358
Nordentoft I et al. Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer. 2011 BMC Cancer pmid:21489314
Woelber L et al. Carbonic anhydrase IX in tumor tissue and sera of patients with primary cervical cancer. 2011 BMC Cancer pmid:21223596
Shi H et al. Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis. 2010 BMC Cancer pmid:20815902
Spindler KL et al. EGFR related mutational status and association to clinical outcome of third-line cetuximab-irinotecan in metastatic colorectal cancer. 2011 BMC Cancer pmid:21439039
Nykopp TK et al. Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma. 2010 BMC Cancer pmid:20875124
Gericke B et al. Microheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients. 2005 BMC Cancer pmid:16225703
Hung MS et al. Identification of hematein as a novel inhibitor of protein kinase CK2 from a natural product library. 2009 BMC Cancer pmid:19419583
Naguib A et al. Dietary, lifestyle and clinicopathological factors associated with BRAF and K-ras mutations arising in distinct subsets of colorectal cancers in the EPIC Norfolk study. 2010 BMC Cancer pmid:20233436
Van der Auwera I et al. Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patients. 2010 BMC Cancer pmid:20226036
Aloysius MM et al. Complete absence of M2-pyruvate kinase expression in benign pancreatic ductal epithelium and pancreaticobiliary and duodenal neoplasia. 2009 BMC Cancer pmid:19754967
Devilard E et al. FGFR1 and WT1 are markers of human prostate cancer progression. 2006 BMC Cancer pmid:17137506
García N et al. A molecular analysis by gene expression profiling reveals Bik/NBK overexpression in sporadic breast tumor samples of Mexican females. 2005 BMC Cancer pmid:16060964
Xu L et al. Expression of growth factor receptors and targeting of EGFR in cholangiocarcinoma cell lines. 2010 BMC Cancer pmid:20565817
Mascolo M et al. Overexpression of Chromatin Assembly Factor-1/p60 helps to predict the prognosis of melanoma patients. 2010 BMC Cancer pmid:20178651
Zhao C et al. Downregulation of SFRP5 expression and its inverse correlation with those of MMP-7 and MT1-MMP in gastric cancer. 2009 BMC Cancer pmid:19586554
Bedin V et al. Fractal dimension of chromatin is an independent prognostic factor for survival in melanoma. 2010 BMC Cancer pmid:20525386
Malfettone A et al. Peritumoral vascular invasion and NHERF1 expression define an immunophenotype of grade 2 invasive breast cancer associated with poor prognosis. 2012 BMC Cancer pmid:22439624
Schneider M et al. Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell marker. 2012 BMC Cancer pmid:22433494
van Cruijsen H et al. Tissue micro array analysis of ganglioside N-glycolyl GM3 expression and signal transducer and activator of transcription (STAT)-3 activation in relation to dendritic cell infiltration and microvessel density in non-small cell lung cancer. 2009 BMC Cancer pmid:19519895
van Houwelingen KP et al. Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from The Netherlands cohort study. 2005 BMC Cancer pmid:15932632
Dierssen JW et al. High-resolution analysis of HLA class I alterations in colorectal cancer. 2006 BMC Cancer pmid:17014712
He HT et al. Siah1 proteins enhance radiosensitivity of human breast cancer cells. 2010 BMC Cancer pmid:20682032
Hamma-Kourbali Y et al. The synthetic peptide P111-136 derived from the C-terminal domain of heparin affin regulatory peptide inhibits tumour growth of prostate cancer PC-3 cells. 2011 BMC Cancer pmid:21624116
Sergeant G et al. Perioperative cancer cell dissemination detected with a real-time RT-PCR assay for EpCAM is not associated with worse prognosis in pancreatic ductal adenocarcinoma. 2011 BMC Cancer pmid:21281486
Partecke IL et al. In vivo imaging of pancreatic tumours and liver metastases using 7 Tesla MRI in a murine orthotopic pancreatic cancer model and a liver metastases model. 2011 BMC Cancer pmid:21276229
Ambrosini-Spaltro A et al. Carcinosarcoma of the colon: report of a case with morphological, ultrastructural and molecular analysis. 2006 BMC Cancer pmid:16836749
Webb M et al. Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis. 2005 BMC Cancer pmid:15717926
Mesquita B et al. No significant role for beta tubulin mutations and mismatch repair defects in ovarian cancer resistance to paclitaxel/cisplatin. 2005 BMC Cancer pmid:16095531